cAC 253

Discontinued Product

cAC 253 (Cat. No. 6549) has been withdrawn from sale for commercial reasons.
Description: Amylin (AMY3) antagonist; brain penetrant
Literature (1)

Biological Activity for cAC 253

cAC 253 is an amylin (AMY3) antagonist (IC50 = 0.3 μM). Protects neuronal cells from Aβ(1-42)-induced cytotoxicity in vitro. Brain penetrant. Improves spatial memory and reduces Aβ plaque number and total area in a mouse Alzheimer's disease model.

Licensing Information

Sold under license from the University of Alberta, US patent 2,967,616, Canadian patent 15/705,789.

Technical Data for cAC 253

M. Wt 3009.36
Formula C126H202N42O40S2

(Modifications: Cys-26 = C-terminal amide, Disulfide bridge between 1 - 26)

Storage Store at -20°C
PubChem ID 134160250
Smiles [H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CC(C)C)NC1=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for cAC 253

References are publications that support the biological activity of the product.

Soudy et al (2016) Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer's disease. Alzheimers Dement. (N Y) 3 44 PMID: 29067318

Mietlicki-Baase (2018) Amylin in Alzheimer's disease: Pathological peptide or potential treatment? Neuropharmacology 136 287 PMID: 29233636

View Related Products by Product Action

View all Calcitonin and Related Receptor Antagonists

Keywords: cAC 253, cAC 253 supplier, cAC253, amylin, antagonists, antagonism, brain, penetrant, AMY3, amyloid, beta, β, Abeta, Calcitonin, and, Related, Receptors, Amyloid, Beta, Peptides, 6549, Tocris Bioscience

Citations for cAC 253

Citations are publications that use Tocris products.

Currently there are no citations for cAC 253.

Reviews for cAC 253

There are currently no reviews for this product. Be the first to review cAC 253 and earn rewards!

Have you used cAC 253?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Peptides Involved in Appetite Modulation Scientific Review

Peptides Involved in Appetite Modulation Scientific Review

Written by Sonia Tucci, Lynsay Kobelis and Tim Kirkham, this review provides a synopsis of the increasing number of peptides that have been implicated in appetite regulation and energy homeostasis; putative roles of the major peptides are outlined and compounds available from Tocris are listed.